Effect of sodium-glucose cotransporter 2 (SGLT2) inhibition on weight loss is partly mediated by liver-brain-adipose neurocircuitry
Keywords: واگوتومی کبدی; Diabetes; Obesity; SGLT2 inhibitor; Glycogen depletion signal; Liver-brain-adipose neurocircuitry; HVx; hepatic vagotomy; SGLT2; sodium-glucose cotransporter 2; TOFO; tofogliflozin; PKA; protein kinase A;